to make sure you can take on more nutrients in your body , and they can be carried in all the mainstream stores .”
Belfontaine highlights the recent WHO report which found no public health risk from CBD : “ There ’ s been a paradigm shift . The marijuana lobby always came from patient advocacy groups that quite honestly were only a whisper when it came to the regulators . It ’ s now coming from the loudspeaker .” Phivida is targeting healthcare practitioners with its clinical line to offer high-grade products in their practice – tinctures with droppers and hard cap pills specially formulated for muscle , bone and joint nutraceuticals with full spectrum CBD hemp oil . “ We ’ re now in the last stages of developing nanoencapsulated tinctures and hard cap pills . There ’ s not a significant price difference – nano has a premium of around 10 %, but you ’ re getting four to five times more medicine into the body .”
In terms of technology , Belfontaine concedes that the industry is still evolving : “ It began as a cottage industry , but it ’ s beginning to take shape with more professional approaches to packaging . We ’ re now seeing production , manufacturing and testing standards equivalent to any natural health products , food or beverages currently sold in mainstream channels . Being involved in the research and development cycle has put us in the ‘ best in class ’ conversation . It ’ s not about being first , but about being the best we can be with a strong sense of purpose and mission allied to the values that drive our company .” It ’ s this mission that drives Belfontaine to deliver the Phivida Families Program , underpinned by values identified by a company icon that depicts a sacred geometric shape known as the seed of life : vida .
51